You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

rare mutations

Showing 1 - 25 of 5,452
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clinical Implications for NSCLC Patients With Rare Mutations

Recruiting
  • NSCLC
  • +2 more
    • Shanghai, Shanghai, China
    • +1 more
    Jan 18, 2023

    NSCLC, RET Driver Mutation, BRAF V600 Mutation Trial in Guanzhou (Toripalimab, Nab paclitaxel, Pemetrexed)

    Recruiting
    • Non-Small Cell Lung Cancer
    • +5 more
    • Toripalimab
    • +3 more
    • Guanzhou, Guangdong, China
      Guangdong Lung Cancer Institute, Guangdong Provincial People's H
    Apr 4, 2023

    HER2 Mutant NSCLC Trial (Pyrotinib maleate)

    Not yet recruiting
    • HER2 Mutant Non-small Cell Lung Cancer
    • Pyrotinib maleate
    • (no location specified)
    Jun 6, 2022

    Efficacy of Immunotherapy With Rare Mutations in Non-small Cell

    Recruiting
    • Non Small Cell Lung Cancer
    • immunity therapy
    • Changsha, Hunan, China
    • +1 more
    Feb 28, 2022

    NSCLC Trial in Guangzhou (Neratinib tablets)

    Not yet recruiting
    • NSCLC
    • Neratinib tablets
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Sep 1, 2023

    Atypical Hemolytic Uremic Syndrome Trial in Ranica (Blood sampling and urine analysis)

    Not yet recruiting
    • Atypical Hemolytic Uremic Syndrome
    • Blood sampling and urine analysis
    • Ranica, BG, Italy
      Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Da
    Mar 28, 2023

    Parkinson Disease Trial in Pozzilli (targeted resequencing)

    Recruiting
    • Parkinson Disease
    • targeted resequencing
    • Pozzilli, Italy
      IRCCS Neuromed
    Sep 27, 2022

    Safety of Almonertinib Trial in Guangzhou (Almonertinib)

    Enrolling by invitation
    • Safety of Almonertinib
    • Guangzhou, Guang Dong, China
      Sun Yat-sen University Cancer Center
    Mar 4, 2021

    Treatment in Carriers of Rare Germline Mutations

    Recruiting
    • Prostate Cancer
      • Sutton, Surrey, United Kingdom
        Institute of Cancer Research and Royal Marsden Hospital
      Mar 30, 2022

      Solid Tumor, Haematological Malignancy, Colorectal Tumors Trial in United Kingdom (Trastuzumab, Pertuzumab)

      Recruiting
      • Solid Tumor
      • +10 more
      • Belfast, United Kingdom
      • +25 more
      Mar 28, 2023

      Diabete Type 2 Trial in Liège (search for rare pathogenic mutations)

      Recruiting
      • Diabete Type 2
      • search for rare pathogenic mutations
      • Liège, Belgium
        Marjorie Fadeur
      Jan 7, 2021

      PTEN Gene Mutation, PTEN Hamartoma Tumor Syndrome Trial in Palo Alto, Boston, Cleveland (RAD001, Placebo)

      Completed
      • PTEN Gene Mutation
      • PTEN Hamartoma Tumor Syndrome
      • Palo Alto, California
      • +2 more
      Feb 7, 2022

      Individuals With Autism and Germline Heterozygous PTEN Mutations

      Recruiting
      • PTEN
      • +4 more
        • Los Angeles, California
        • +4 more
        Jul 29, 2021

        Treatment, Treatment Side Effects Trial in China (YK-029A)

        Recruiting
        • Treatment
        • Treatment Side Effects
        • Hefei, Anhui, China
        • +34 more
        Mar 15, 2023

        Alpha-1 Antitrypsin Deficiency (AATD), Pi*ZZ, Pi*SZ, Pi*Null, Another Rare Phenotype/Genotype Known to be Associated With Either

        Recruiting
        • Alpha-1 Antitrypsin Deficiency (AATD)
        • +2 more
        • Alvelestat (MPH966)
        • Placebo
        • Birmingham, Alabama
        • +8 more
        Aug 31, 2021

        Rare CFTR Mutation Cell Collection Protocol (RARE)

        Recruiting
        • Cystic Fibrosis
          • Birmingham, Alabama
          • +5 more
          Aug 22, 2022

          Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney

          Recruiting
          • Rare Disorders
          • +309 more
            • Sioux Falls, South Dakota
            • +1 more
            Jun 20, 2022

            Genetic Architecture of Neutrophil-Mediated Inflammatory Skin

            Not yet recruiting
            • Neutrophil-mediated Inflammatory Dermatoses
            • Inflammatory Dermatoses
            • Analysis of samples
            • Basel, Switzerland
              University Hospital Basel, Clinic of Dermatology
            Feb 20, 2023

            Cystinosis, Cystinosis, Nephropathic, Spinal Muscular Atrophy Trial in Germany (molecular-based screening)

            Completed
            • Cystinosis
            • +2 more
            • molecular-based screening
            • Rosenheim, Bavaria, Germany
            • +3 more
            Aug 30, 2023

            Cystinosis, Primary Hyperoxaluria Trial in Hanover (Diagnostic test)

            Recruiting
            • Cystinosis
            • Primary Hyperoxaluria
            • Diagnostic test
            • Hanover, Lower Saxony, Germany
              Screening Laboratory Hanover
            Apr 24, 2023

            Lung Diseases, Respiratory Distress Syndrome, Newborn, Pulmonary Surfactant Trial in Saint Louis

            Recruiting
            • Lung Diseases
            • +3 more
              • Saint Louis, Missouri
                Washington University School of Medicine
              Nov 22, 2022

              Interstitial Lung and Liver Disease, Infantile Liver Failure Syndrome 1, Neurologic, Endocrine and Pancreatic Disease,

              Not yet recruiting
              • Interstitial Lung and Liver Disease
              • +3 more
              • Procedure/Surgery
              • Paris, France
                Hôpital Necker-Enfants Malades
              Aug 22, 2022

              Lung Cancer Trial in Boston, Nashville

              Active, not recruiting
              • Lung Cancer
                • Boston, Massachusetts
                • +1 more
                Dec 28, 2022

                Gene Editing as a Therapeutic Approach for Rett Syndrome

                Recruiting
                • Rett Syndrome
                • Gene editing in vitro
                • Siena, Italy
                  University of Siena
                Feb 13, 2023

                Osimertinib for NSCLC With Uncommon EGFR Mutations

                Enrolling by invitation
                • Carcinoma, Non-Small-Cell Lung
                • Genes, erbB-1
                • Ramat Gan, Israel
                  Sheba Medical Centre
                Jun 14, 2022